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Abstract
Background: Deviations from Hardy-Weinberg equilibrium (HWE) are commonly thought of as
indicating genotyping errors, population stratification or some other artefact. However they could
also arise through important biological mechanisms. In particular, genetic variants having a recessive
effect on the successful fertilisation and/or development of an embryo might be manifest through
such deviations in an unselected sample of "control" subjects.
Findings: We investigated genotypes from 463842 autosomal markers from 1504 British subjects.
We identified regions in which several neighbouring markers exhibited deviation from HWE in the
same direction by considering "heterozygosity scores" in windows of 10 markers. The
heterozygosity score for each marker was defined as -log(p) or log(p) according to whether the
marker demonstrated increased heterozygosity or homozygosity. In each window the marker with
the highest absolute score was ignored and the positive and negative scores were summed for the
other nine markers. Windows were selected on the basis of this sum exceeding a given threshold,
for which we used values of 50 or 15.
For the threshold of 50, we identified 7 regions with increased heterozygosity and for the threshold
of 15 we identified 22 regions with increased heterozygosity, 23 with increased homozygosity and
2 containing both kinds of window. The most impressive of these results came from a group of 6
markers at 17q21, each of which showed increased heterozygosity significant at p < 10-190.
Conclusion: The human genome contains regions which deviate markedly from HWE and these
might harbour genes influencing embryonic survival.
Findings
When marker allele frequencies in controls deviate mark-
edly from Hardy-Weinberg equilibrium (HWE) this is
commonly taken as an indicator that the genotyping is
unreliable or that there is marked population stratifica-
tion and the marker is discarded [1]. However if common
polymorphisms influence embryonic survival then it is
expected that these may also lead to such deviations. The
existence of such loci is supported by a genome-wide ten-
dency for siblings to share alleles more than would be
expected by chance [2].
As previously suggested, we reasoned that if groups of
nearby markers all showed deviation from HWE then this
could not result purely from genotyping errors since there
would be no reason for the same kind of error to be repli-
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cated in each marker [3]. Hence we used the control data
from the 1958 British Birth Cohort which we obtained
online from the Wellcome Trust Case-Control Consor-
tium (WTCCC) after their approval was granted [4]. We
used the genotypes called by the Chiamo algorithm and
excluded those having either a studywise missing data
proportion of more than 0.05 or a studywise minor allele
frequency of less than 0.05 along with a studywise missing
data proportion of more than 0.01. Naturally, for the pur-
poses of this study, we did not exclude markers on
grounds of deviation from HWE. Genotypes for 463842
autosomal markers were investigated, typed in 1504 sub-
jects. We used sliding windows of ten markers across the
sample and for each of the ten markers in each window we
checked for deviation from HWE using a chi-squared test
and recorded the resultant p-values. We assigned a "heter-
ozygosity score" which was defined as -log10 (p) for mark-
ers showing increased heterozygosity (i.e. a positive
number) and as log10 (p) for those showing increased
homozygosity. We then excluded the marker having the
highest absolute value for this score and considered only
the scores from the other nine markers. The aim of the
approach was to ignore regions where only a single
marker produced a marked deviation from HWE but to
identify those in which a group of markers all supported
deviation in the same direction. We then summed all the
positive heterozygosity scores and all the negative hetero-
zygosity scores from the nine markers and tested whether
the absolute value of either sum exceeded a predeter-
mined threshold. For the current study, we used threshold
values of 15 and of 50.
For each set of ten markers reaching the specified thresh-
old using this process, we went on to investigate departure
from HWE of two-marker and three-marker haplotypes
using a method we have described elsewhere [5] to pro-
duce a one degree of freedom chi-squared test for depar-
ture from HWE, summarised by a "heterozygosity score"
defined as -log10 (p) or log10 (p).
When there were overlapping sets of ten markers which
exceeded the threshold they were amalgamated together,
building up regions in which there was evidence for devi-
ation from HWE. We obtained lists of genes within 200 kb
either side of these regions by interrogating the UCSC
genome browser [6].
Table 1, 2, 3, 4, 5, 6 show the results when we applied a
threshold of 50 to identify sets of markers demonstrating
deviation from HWE. (Additional File 1 is Table S5:
HWETable5.doc and Additional File 2 is Table S6:
HWETable6.doc. Results using a threshold of 15 are pre-
sented in Additional File 3 Table S7: HWETable7.doc.)
Using the threshold of 50, 7 regions were identified as
showing increased heterozygosity. In addition, there were
68 markers which individually produced results signifi-
cant at p < 10-50 but which were not supported by other
markers nearby and hence which might represent geno-
typing errors, of which 10 demonstrated increased heter-
ozygosity and 58 increased homozygosity. Using a
threshold of 15 implicated 22 regions and 37 isolated
markers as showing increased heterozygosity and 23
regions and 285 isolated markers as showing increased
homozygosity. There were 2 regions containing a mixture
of 10-marker windows meeting the criterion of 15 for
both increased heterozygosity and homozygosity.
The most convincing evidence for a real departure from
HWE occurs at 17q21 in the region around rs2693363, as
shown in Table 4. This marker and five others flanking it
are each individually significant at p < 10-190. It does not
seem plausible that this result could occur through a set of
genotyping errors or through some other artefact and so
we can only conclude that there really is a marked excess
of heterozygosity in this region. Using the threshold of 50,
it seems unlikely that any of the results could have
occurred by chance. Perhaps the least convincing result is
at 6p25.3 (Table 2), where rs815593 had a heterozygosity
score of 100.6 and rs11757245 has a score of 86.9. No
other markers nearby support deviation from HWE and
one could argue that it is possible that the result for each
marker is due to genotyping error and that it is mere coin-
cidence that the two happen to lie close to each other.
When the threshold is set as low as 15, we expect that a
number of the results might have occurred by chance.
Given that results from nearby markers are not independ-
ent, it is possible that a region might happen to show devi-
ation from HWE at p < 10-3 or p < 10-4 and that several
markers in this region might be significant at this level
and hence produce a combined score exceeding the
threshold of 15. On the other hand, many regions pro-
duced a score far in excess of this and a substantial propor-
tion of regions identified using this lower threshold are
likely to represent a real biological effect.
With regard to the comparison of single marker and hap-
lotype-based analyses, there were no regions in which
there was a haplotype analysis which provided stronger
evidence for increased heterozygosity than the most sig-
nificant single marker analysis. We would take this to
indicate that the information supporting departure from
HWE was captured by the single marker. For example,
given the allele frequencies of rs11757245 at 6p25.3
(Table 2), one would expect 204.4 subjects to have geno-
type BB. In fact, this genotype occurs in only 14 subjects,
a finding consistent with this polymorphism itself or one
in close LD with it having a marked effect on survival.
However when we considered regions in which there was
a deviation towards excess homozygosity rather than het-
erozygosity, identified using the threshold of 15, thereBMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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Table 1: Region of 1q31-41 with summed heterozygosity score exceeding 50.
Marker or 
gene
Position Marker genotype counts
Observed
Expected
Heterozygosity scores for single, two and 
three marker analysis
Gene description
AA AB BB 1 2 3
CAMSAP1L1 198975309 Start calmodulin regulated 
spectrin-associated 
protein 1-like 1
CAMSAP1L1 199096455 End
GPR25 199108789 Start G protein-coupled 
receptor 25
GPR25 199109874 End
C1orf106 199127292 Start chromosome 1 open 
reading frame 106
rs2792810 199146603 1468 0 12 -6.1 -6.1 -0.9
1456.1 23.8 0.1
rs3767424 199148779 1480 0 0 0 -0.1 13.4
1480 0 0
C1orf106 199151486 End
C1orf81 199151855 Start chromosome 1 open 
reading frame 81
rs805909 199160517 1143 312 25 -0.1 13.4 3.9
1140.1 317.7 22.1
rs1819043 199163659 345 940 195 26.4 9 8.8
448.8 732.4 298.8
rs3767421 199163817 382 753 345 0.3 0.3 8.7
388.7 739.5 351.7
rs805911 199172076 1463 17 0 0 24.7 8.8
1463 16.9 0
rs705736 199173739 361 933 186 25.4 9 8.2
462.7 729.7 287.7
C1orf81 199202415 End
KIF21B 199205143 Start kinesin family member 
21BBMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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were a few for which a haplotype analysis was more signif-
icant than any single marker analysis. One interpretation
of this might be that there could be an untyped polymor-
phism in LD with one or more of the haplotypes. For
example, the frequencies at rs649022 at 4q26 of both the
AA and BB genotypes are somewhat increased from HWE
with p < 10-12 (Additional File 3 Table S7). When the hap-
lotypes of this marker are considered along with the next
two markers, rs594125 and rs11726138, the deviation in
favour of increased homozygosity is significant at p < 10-
20. Inspection of the counts of haplotype combinations
revealed that the haplotypes BAB and AAB were
homozygous approximately twice as often as would be
expected under HWE, with expected counts of 48.6 and
27.5 and observed counts of 83 and 59, respectively.
For most of the regions implicated there were a number of
different genes within 200 kB, making it impossible to
draw firm conclusions about which might harbour bio-
logically meaningful polymorphisms. It would be diffi-
cult to avoid making subjective judgements about the
relative weight given to statistical evidence and to biolog-
ical plausibility. For example, a number of markers
around rs1326581 at 6p12.2 combined to provide rela-
tively weak statistical evidence for increased homozygos-
ity (only just exceeding the threshold of 15, Additional
File 3 Table S7), yet these markers span PKHD1, the gene
for polycystic kidney and hepatic disease, mutations in
which are a known cause of autosomal recessive kidney
disease (ARKD) which can result in stillbirth or death in
infancy or childhood. By contrast, as we have already
noted there is extremely strong statistical evidence to sup-
port increased homozygosity around rs2693363 at
17q21.31 (Table 4) but none of the identified genes in the
region are really obvious candidates to have a recessive
lethal effect.
One indication for genes having a biologically significant
role in influencing departures from HWE might be that
similar genes were found in different implicated regions.
There were several possible examples of this phenom-
emon which were apparent when the threshold of 15 was
considered, as shown in Additional File 3 Table S7. Two
cytogenetically distinct implicated regions contain
CSMD1 and CSMD3, the genes for CUB and Sushi multi-
ple domains 1 and 3, although the third gene of the fam-
ily, CSMD2, did not occur in an implicated region. Three
loci related to ribosomal protein S26 were in separated
implicated regions: LOC728937 (similar to 40S ribos-
omal protein S26), RPS26P3 (ribosomal protein S26
pseudogene 3) and LOC644191 (40S ribosomal protein
S26). However the gene for ribosomal protein S26 itself,
rs7522991 199223808 383 754 343 0.3 0.2 8.3
390.3 739.5 350.3
rs6696611 199225346 395 742 343 0.1 8 7.9
396.5 739.1 344.5
rs705747 199236940 366 936 178 26.5 26 8.7
470 728.1 282
rs697455 199243733 1468 12 0 0 0.3 0.3
1468 12 0
rs3767406 199243903 383 754 343 0.3 0.3 0
390.3 739.5 350.3
rs497824 199256967 1468 12 0 0 0 0
1468 12 0
KIF21B 199259451 End
The table shows markers and genes in a region of 1q31-41 showing increased heterozygosity using a threshold for the summed heterozygosity 
scores (ignoring the highest-scoring marker) exceeeding 50. Observed counts are shown for each marker genotype with the expected counts in the 
row below. Heterozygosity scores, defined as -log(p) for increased heterozygosity and log(p) for increased homozygosity, are shown for individual 
markers and for two and three marker haplotypes.
Table 1: Region of 1q31-41 with summed heterozygosity score exceeding 50. (Continued)BMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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Table 2: Region of 6p23-25.3 with summed heterozygosity score exceeding 50.
Marker or 
gene
Position Marker genotype counts
Observed
Expected
Heterozygosity scores for single, two and 
three marker analysis
Gene description
AA AB BB 1 2 3
OR4F1P 50822 Start olfactory receptor, family 
4, subfamily F, member 1 
pseudogene
OR4F1P 51956 End
LOC646070 59339 Start similar to capicua 
homolog
LOC646070 89509 End
LOC1001322
66
89746 Start similar to hCG2014367
LOC1001322
66
91534 End
FLJ43763 148313 Start hypothetical protein 
LOC642316
FLJ43763 148839 End
rs6927090 197145 1456 24 0 0 0.2 0.2
1456.1 23.8 0.1
rs12197235 197772 1129 333 18 0.3 0.2 0.7
1134 323 23
rs2181107 214735 1456 24 0 0 0.8 2.6
1456.1 23.8 0.1
rs734674 224695 1211 266 3 0.7 2.5 55.5
1220.5 247 12.5
rs815583 230695 961 505 14 4 58.2 43.2
995 437 48
DUSP22 237101 Start dual specificity 
phosphatase 22
rs815593 239457 166 1151 163 100.6 69.6 59.8
371.5 740 368.5
rs7754000 248017 1201 262 17 -0.1 0.2 0.3
1198.8 266.4 14.8BMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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RPS26, was not in an implicated region and nor was
RPS26L1 (ribosomal protein S26-like 1). Two loci related
to FMR1 were in separate implicated regions: NUFIP1P
(nuclear fragile × mental retardation protein interacting
protein 1 pseudogene) and CYF1P1 (cytoplasmic FMR1
interacting protein 1), although NUF1P1 and CYF1P2
were not. Three loci related to golgin subfamily a were in
different implicated regions: LOC643707 (golgi autoanti-
SNP_A-
4299501
260197 1322 158 0 0.3 0.8 69.7
1326.2 149.6 4.2
rs12198312 268326 1071 381 28 0.2 69.5 68
1075.3 372.5 32.3
rs11757245 273070 394 1072 14 86.9 80.2 79.5
584.4 691.2 204.4
rs3800250 279825 1375 104 1 0.1 0.1 0.1
1375.9 102.2 1.9
rs7763092 294386 1439 41 0 0 0.2 0.6
1439.3 40.4 0.3
DUSP22 296355 End
rs2671415 312109 1298 180 2 0.3 0.6 0.6
1301.7 172.6 5.7
rs9501958 323970 1284 196 0 0.5 0.4 0
1290.5 183 6.5
rs7745887 329546 1435 45 0 0 0 0
1435.3 44.3 0.3
IRF4 336760 Start interferon regulatory 
factor 4
IRF4 356193 End
EXOC2 430138 Start exocyst complex 
component 2
LOC727827 469180 Start hypothetical protein 
LOC727827
LOC727827 470524 End
LOC642335 481199 Start hypothetical LOC642335
LOC642335 483632 End
EXOC2 638109 End
Table 2: Region of 6p23-25.3 with summed heterozygosity score exceeding 50. (Continued)BMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
Page 7 of 11
(page number not for citation purposes)
Table 3: Region of 8p23.3 with summed heterozygosity score exceeding 50.
Marker or 
gene
Position Marker genotype counts
Observed
Expected
Heterozygosity scores for single, two and 
three marker analysis
Gene description
AA AB BB 1 2 3
KBTBD11 1909451 Start kelch repeat and BTB 
(POZ) domain 
containing 11
KBTBD11 1942509 End
MYOM2 1980565 Start myomesin (M-protein) 
2, 165 kDa
MYOM2 1980565 Start myomesin (M-protein) 
2, 165 kDa
MYOM2 2080787 End
MYOM2 2080787 End
rs1478960 2137223 1316 160 4 0 0.4 1
1316.8 158.5 4.8
rs1382608 2151988 372 772 336 1 1.5 1.1
388.2 739.6 352.2
rs7838658 2152119 688 658 134 0.6 0.8 0.9
698.8 636.3 144.8
rs2127175 2188481 1272 203 5 0.2 0.2 -8.5
1274.7 197.7 7.7
rs1037704 2189117 1418 62 0 0.1 -10.6 0
1418.6 60.7 0.6
rs2607684 2189919 753 509 218 -11.7 -0.1 -0.3
685.8 643.3 150.8
rs10111921 2200103 644 760 76 10.9 4.9 36.8
708.5 631 140.5
rs2618872 2218978 1161 302 17 0.1 44.4 80.4
1163.1 297.9 19.1
rs2605037 2219069 456 971 53 49.5 98.1 71.4
598.9 685.1 195.9BMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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gen, golgin subfamily a, 6 pseudogene), LOC192130
(golgi autoantigen, golgin subfamily a, 4 pseudogene)
and LOC729786 (similar to golgi autoantigen, golgin
subfamily a, 8A). However the UCSC browser lists loci
containing the phrase "golgin subfamily a" in 11 other
regions which did not show departure from HWE. Finally,
olfactory receptor genes and/or pseudogenes were found
in four different implicated regions but there are over 400
of these distributed in a number of genomic regions.
This simple exploratory analysis clearly demonstrates that
there are regions of the human genome which deviate
markedly from HWE in a sample of unselected British
adults. The evidence is stronger for some regions than for
others and we have not attempted to quantify this on the
rs2013135 2226740 278 1148 54 107.5 80.5 53.4
490.5 723 266.5
rs315225 2231722 510 901 69 31.6 24.4 20.3
623.4 674.3 182.4
rs7015044 2234017 513 834 133 13 10 17
584.4 691.2 204.4
rs1159923 2234501 1197 274 9 0.3 19.7 19
1202.4 263.2 14.4
rs931093 2243578 599 767 114 7.6 8.2 24.2
652.2 660.5 167.2
rs2605035 2257735 1401 79 0 0.1 16.6 0.2
1402.1 76.9 1.1
rs6558636 2257979 589 814 77 16.8 0 -2.7
670.3 651.4 158.3
rs6558637 2258129 594 534 352 -21.5 -8.5 -5.9
500.9 720.2 258.9
rs4876160 2258259 907 498 75 -0.2 0.3 0.1
902.9 506.1 70.9
rs1614403 2258689 1145 325 10 0.7 0 0
1155.1 304.8 20.1
rs2260185 2259833 1411 69 0 0.1 14.9 0
1411.8 67.4 0.8
rs11136507 2259919 663 767 50 15.3 0 0
740 613.1 127
Table 3: Region of 8p23.3 with summed heterozygosity score exceeding 50. (Continued)BMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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Table 4: Region of 17q21 with summed heterozygosity score exceeding 50.
Marker or 
gene
Position Marker genotype counts
Observed
Expected
Heterozygosity scores for single, two and 
three marker analysis
Gene description
AA AB BB 1 2 3
LOC339192 40652465 Start hypothetical protein 
LOC339192
FMNL1 40655075 Start formin-like 1
LOC339192 40675042 End
FMNL1 40680468 End
C17orf46 40687543 Start chromosome 17 open reading 
frame 46
C17orf46 40695262 End
MAP3K14 40696271 Start mitogen-activated protein 
kinase kinase kinase 14
MAP3K14 40750197 End
rs4792855 40815480 405 746 329 0.2 0.3 0.3
409 738 333
rs1230094 40825939 751 622 107 0.6 0.7 0.6
762.1 599.9 118.1
rs732589 40826543 762 617 101 0.7 0.6 0.5
774.3 592.4 113.3
ARHGAP27 40827058 Start Rho GTPase activating protein 
27
rs1230103 40841574 753 619 108 0.5 0.5 0.2
762.8 599.5 117.8
rs12947718 40848884 977 458 45 0.3 0 0
982.7 446.5 50.7
ARHGAP27 40858780 End
LOC201175 40862501 Start hypothetical protein 
LOC201175
LOC201175 40867570 End
PLEKHM1 40869049 Start pleckstrin homology domain 
containing, family M (with 
RUN domain) member 1BMC Research Notes 2009, 2:29 http://www.biomedcentral.com/1756-0500/2/29
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rs17631303 40872185 1036 399 45 -0.2 0 -0.1
1031.4 408.2 40.4
rs3946526 40897439 980 455 45 0.3 0.1 49.4
985.2 444.7 50.2
rs2078200 40897617 803 573 104 0 80.1 79.7
802 574.9 103
PLEKHM1 40923893 End
LOC644354 40934084 Start similar to Apoptosis-related 
protein 2 (APR-2)
LOC644354 40934428 End
LRRC37A4 40939890 Start leucine rich repeat containing 
37, member A4 (pseudogene)
LRRC37A4 40948305 End
rs2696639 41006823 89 1312 79 193.6 193.6 191.3
375 740 365
rs2696640 41007016 88 1312 80 193.6 192 192
374 740 366
rs2693363 41007205 93 1307 80 190.3 192.6 192.6
376.5 739.9 363.5
rs2693364 41007294 87 1314 79 195 195 153.4
374 740 366
rs2693371 41011471 87 1314 79 195 153.4 153.4
374 740 366
rs17642476 41012163 1298 182 0 0.4 153.4 75.8
1303.6 170.8 5.6
rs2463520 41015138 87 1314 79 195 98.8 98.8
374 740 366
LOC644157 41018375 Start similar to dead end homolog 1
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basis of a formal statistical test. The nature of our
approach means that we have only sought to identify
regions in which the effect is apparent in more than one
marker. It is quite likely that at least some of the single
markers showing deviation from HWE which we have
ignored do so because of a real effect rather than through
genotyping error although we note that they more often
showed increased homozygosity whereas the regions
implicated by groups of markers showed more marked
deviations towards heterozygosity. This may suggest that
a substantial proportion of these isolated markers do rep-
resent genotyping errors. Likewise, the marker set we have
used does not provide 100% coverage of the genome.
Hence there may be many more regions of HWE present
than those highlighted by the present study.
Although it seems clear that deviations from HWE exist,
the mechanisms driving this are not clear. One proposal
we made is that a recessive lethal polymorphism could
lead to decreased homozygosity in surviving subjects.
Such a polymorphism might cause death antenatally or in
childhood or might prevent successful fertilisation. We
argue that the effect on reproductive fitness of the parent
would be minimal if it produced very early termination or
prevented fertilisation. Nevertheless, such polymor-
phisms would need to be very common indeed if they
were to be detectable in a sample size of only 1504, as we
have used.
Although the best implicated regions demonstrate
increased heterozygosity, we also find regions with
increased homozygosity, some with p values less than 10-
10  or 10-20  or even smaller. Theoretically, increased
homozygosity could occur through the presence of dele-
tions or population stratification but is seems hard to con-
ceive that these mechanisms could produce an effect of
such magnitude.
To conclude, we have obtained good evidence that some
regions of the human genome demonstrate deviation
from HWE in an unselected sample of adults from the UK
population. We believe that these preliminary findings
warrant further exploration.
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